Quantcast

Latest Insulin pen Stories

2011-07-11 10:43:00

BOCA RATON, Fla., July 11, 2011 /PRNewswire/ -- American Scientific Resources, Inc. ("American Scientific Resources" or the "Company") (OTCQB: ASFX) and its distributor, School Health Corporation, today announced that they have received a purchase order from School Health Corporation for 108 Disintegrator Plus units to be delivered to a single school district to meet their needle disposal needs. (Logo: http://photos.prnewswire.com/prnh/20110124/NY34439LOGO ) The Disintegrator Plus(TM) is...

2011-06-27 00:00:00

PARIS, June 27, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71st Scientific American Diabetes Association Sessions 2011, the results of three studies showing that people with diabetes using Sanofi insulins Lantus(R) and/or Apidra(R) with the insulin delivery device SoloSTAR(R) experienced greater treatment satisfaction, better quality of life and lower fear of hypoglycemia vs those using a premixed insulin product. The goal of the...

2011-06-07 07:00:00

BRIDGEWATER, N.J., June 7, 2011 /PRNewswire/ -- Actors Paul and Mira Sorvino today announce the Diabetes Co-Stars: Cook-Off. This nationwide recipe contest runs from June 7-July 20, 2011 and is a continuation of their work with sanofi-aventis U.S. on the Diabetes Co-Stars awareness campaign, which is designed to help educate people living with diabetes and those who support them. To view the multimedia assets associated with this release, please click:...

2011-03-24 06:00:00

ST. PETERSBURG, Fla., March 24, 2011 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, is partnering with 2011 IZOD IndyCar Series driver Charlie Kimball to launch the educational program, Drive the Switch, encouraging diabetes patients who use insulin and caregivers to pledge to talk to their health care professional about options for insulin delivery, like the prefilled insulin pen device. Nearly 90 years since the discovery of insulin, Americans still have not embraced...

2011-01-19 06:00:00

CRAWLEY, England, January 19, 2011 /PRNewswire/ -- A 2010 GOOD DESIGN(TM) Award[1] has been awarded to Novo Nordisk for NovoPen Echo(R), the latest innovation in pen development - designed specifically with the needs of children in mind. Judging is made based on product design which is new, visionary and innovative and that may enrich people's lives. More than 400,000 children are diagnosed with Type 1 diabetes worldwide[2] and these children may need to inject themselves multiple...

2010-10-04 09:45:00

PRINCETON, N.J., Oct. 4 /PRNewswire/ -- Novo Nordisk, a global healthcare company and leader in diabetes care, today announced a $73 million expansion of its Clayton, NC manufacturing facility to accommodate increased production capacity for the Company's insulin delivery devices. The initial expansion will create 205 new jobs, including 85 in the Novo Nordisk Clayton facility, which currently produces a number of products, including the Levemir®...

2010-07-26 07:30:00

REDWOOD CITY, Calif., July 26 /PRNewswire/ -- Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse(TM) insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a small, adhesively attached, flat...

2010-07-02 16:23:15

Labels on the popular insulin pen used by people with diabetes warn against visually-impaired people using pens to measure out and administer their insulin dosage. A Case Western Reserve University pilot study from the Frances Payne Bolton School of Nursing overturns that thinking, finding that visually impaired people actually did slightly better than their seeing peers, although the difference was not statistically significant. Ann S. Williams, the lead investigator of the study, "A...

2010-01-11 01:14:00

DUSSELDORF, Germany, January 11 /PRNewswire-FirstCall/ -- - Expansion of Cooperation With Diabetes Leader Novo Nordisk - Important Step in the Worldwide Development of Medical Plastic Systems The Gerresheimer Group has set up a new facility for medical plastic systems in Indaiatuba (Brazil). The plant is to commence operations early in 2010. On the basis of a long-term cooperation agreement with Novo Nordisk, components will be produced with state-of-the-art technology for...

2009-12-07 15:00:00

INDIANAPOLIS, Dec. 7 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced the availability of a smaller insulin vial, the first in the United States containing 3 mL (300 units) of insulin, for people with diabetes being treated in a hospital. The new smaller vial - for Lilly's Humalog® (insulin lispro injection [rDNA origin]) and Humulin® R-U100 (regular insulin human injection, USP [rDNA origin)]) - is intended to provide...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related